Synapse - Matthew Margolis

Matthew Margolis

Research Focus

Former Employee. MEDICINE; Research Stdy Specialist

Recent additions – View all

Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
Journal Article

Greally, M.; Chou, J. F.; Chatila, W. K.; Margolis, M.; Capanu, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Daian, F.; Ladanyi, M.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Journal Article

Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
Gastric Cancer (2019)

Fulltext@MSK | Save
Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
Meeting Abstract

Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications